EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AARS1 promotes tumor progression and immune evasion via ATF6 lactylation-mediated tryptophan metabolism in hepatocellular carcinoma

Yiming Wang, Fan Li, Jiongyuan Li, Tianning Huang, Tian Huang, Nan Zhang, Yiran Li, Ziyu Xun, Zhe Zhu, Qiaorui Tan, Xuanyu Zhao, Liangwei Zou und 11 weitere

Cell Metabolism · 2026-08 · 38 (8) · 1702-1721.e11

DOI: 10.1016/j.cmet.2026.06.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Metabolism, 2026-08. Verfasst von Yiming Wang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; Department of Liver Surgery, State Key Labo…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Tryptophan, Activating Transcription Factor 6. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycolysis and protein lactylation both drive hepatocellular carcinoma (HCC) progression, yet their mechanistic interplay remains unclear. Through integrated single-cell and spatial transcriptomic analyses stratified by glycolytic activity, we identified alanyl-tRNA synthetase 1 (AARS1), a recently characterized protein lactyltransferase, as a key metabolic-immune regulator in HCC. Clinically, AARS1 is upregulated in tumors, correlates with elevated glycolytic flux measured by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT), poor prognosis, and immunotherapy resistance. In murine models, hepatocyte-specific knockout of AARS1 suppressed tumor growth and reduced the abundance of regulatory T cells (Tregs). Mechanistically, AARS1 catalyzes the lactylation of activating transcription factor 6 (ATF6) at lysine 424, preventing its degradation and leading to transcriptional activation of TDO2. This process promotes L-kynurenine production and supports Treg differentiation and function. Furthermore, L-kynurenine-AHR signaling drives eNAMPT secretion from Tregs, which augments tumor cell glycolysis and lactate production, thereby reinforcing a feedback loop that sustains AARS1-catalyzed ATF6 lactylation. Pharmacological inhibition of AARS1 with β-alanine sensitized tumors to PD-1/PD-L1 blockade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularTryptophanActivating Transcription Factor 6Immune EvasionAnimalsHumansMiceT-Lymphocytes, RegulatoryDisease ProgressionCell Line, TumorGlycolysis

Stichwörter der Autor:innen

AARS1ER stressHCCTregimmune evasionlactylationtryptophan metabolism

Substanzen

TryptophanActivating Transcription Factor 6

Autor:innen und Institutionen

  • Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical Colleg…
  • Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
  • Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
  • Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing 210009, China.
  • Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. Electronic address: wanghao_@njmu.edu.cn.
  • Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. Electronic address: niming@njmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Wang, Y., Li, F., Li, J., Huang, T., Huang, T., Zhang, N., Li, Y., Xun, Z., Zhu, Z., Tan, Q., Zhao, X., Zou, L., Piao, M., Li, C., Sun, B., Ma, J., Chen, P., Gu, J., Dai, S., …, & Lu, L. (2026). AARS1 promotes tumor progression and immune evasion via ATF6 lactylation-mediated tryptophan metabolism in hepatocellular carcinoma. Cell Metabolism, 38(8), 1702-1721.e11. https://doi.org/10.1016/j.cmet.2026.06.003

Vancouver

Wang Y, Li F, Li J, Huang T, Huang T, Zhang N, et al. AARS1 promotes tumor progression and immune evasion via ATF6 lactylation-mediated tryptophan metabolism in hepatocellular carcinoma. Cell Metabolism. 2026;38(8):1702-1721.e11. doi:10.1016/j.cmet.2026.06.003

BibTeX
@article{Wang2026,
  author = {Wang, Yiming and Li, Fan and Li, Jiongyuan and Huang, Tianning and Huang, Tian and Zhang, Nan and Li, Yiran and Xun, Ziyu and Zhu, Zhe and Tan, Qiaorui and Zhao, Xuanyu and Zou, Liangwei and Piao, Mingjian and Li, Chengjie and Sun, Boyu and Ma, Jingwen and Chen, Pengyao and Gu, Jian and Dai, Shipeng and Wang, Hao and Ni, Ming and Zhao, Haitao and Lu, Ling},
  title = {AARS1 promotes tumor progression and immune evasion via ATF6 lactylation-mediated tryptophan metabolism in hepatocellular carcinoma},
  journal = {Cell Metabolism},
  year = {2026},
  volume = {38},
  number = {8},
  pages = {1702--1721.e11},
  doi = {10.1016/j.cmet.2026.06.003}
}
Kostenlos starten →